Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells.

Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, Berking C, Schaft N, Dörrie J (2025)

Publication Type: Journal article

Publication year: 2025

Journal

MedComm Wiley

Book Volume: 6

Journal Issue: 3

DOI: 10.1002/mco2.70111

Authors with CRIS profile

Tatjana Sauerer Department of Dermatology Franziska Bremm Department of Dermatology Amke Beenen Department of Operative Dentistry and Periodontology Lukas Heger Department of Dermatology Diana Dudziak Professur für die Biologie Dendritischer Zellen Michael Erdmann Department of Dermatology Carola Berking Lehrstuhl für Haut- und Geschlechtskrankheiten Niels Schaft Medizinische Fakultät Jan Dörrie Department of Dermatology

How to cite

APA:

Sauerer, T., Bremm, F., Beenen, A., Heger, L., Dudziak, D., Bosch, N.C.,... Dörrie, J. (2025). Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. MedComm, 6(3). https://doi.org/10.1002/mco2.70111

MLA:

Sauerer, Tatjana, et al. "Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells." MedComm 6.3 (2025).

BibTeX: Download